• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与 HCV RNA 相比,HCV 核心抗原与 HCV/HIV-1 共感染患者的 CD4+ T 细胞计数相关性更高。

A higher correlation of HCV core antigen with CD4+ T cell counts compared with HCV RNA in HCV/HIV-1 coinfected patients.

机构信息

Department of Microbiology and Infectious Disease Center, Peking University Health Science Center, Beijing, China.

出版信息

PLoS One. 2011;6(8):e23550. doi: 10.1371/journal.pone.0023550. Epub 2011 Aug 12.

DOI:10.1371/journal.pone.0023550
PMID:21858166
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3155566/
Abstract

Development of HCV infection is typically followed by chronic hepatitis C (CHC) in most patients, while spontaneous HCV viral clearance (SVC) occurs in only a minority of subjects. Compared with the widespread application of HCV RNA testing by quantitative RT-PCR technique, HCV core antigen detection may be an alternative indicator in the diagnosis of hepatitis C virus infections and in monitoring the status of infectious individuals. However, the correlation and differences between these two indicators in HCV infection need more investigation, especially in patients coinfected by HIV-1. In this study, a total of 354 anti-HCV and/or anti-HIV serum positive residents from a village of central China were enrolled. Besides HCV-related hepatopathic variables including clinical status, ALT, AST, anti-HCV Abs, as well as the altered CD4+/CD8+ T cell counts, HCV core antigen and HCV viral load were also measured. The concentration of serum HCV core antigen was highly correlated with level of HCV RNA in CHC patients with or without HIV-1 coinfection. Of note, HCV core antigen concentration was negatively correlated with CD4+ T cell count, while no correlation was found between HCV RNA level and CD4+ T cell count. Our findings suggested that quantitative detection of plasma HCV core antigen may be an alternative indicator of HCV RNA qPCR assay when evaluating the association between HCV replication and host immune status in HCV/HIV-1 coinfected patients.

摘要

丙型肝炎病毒(HCV)感染的发展通常在大多数患者中随后会出现慢性丙型肝炎(CHC),而只有少数患者会自发清除 HCV 病毒(SVC)。与广泛应用 HCV RNA 检测的定量 RT-PCR 技术相比,HCV 核心抗原检测可能是诊断丙型肝炎病毒感染和监测感染个体状态的替代指标。然而,这两种指标在 HCV 感染中的相关性和差异需要更多的研究,特别是在 HIV-1 合并感染的患者中。在这项研究中,共纳入了来自中国中部一个村庄的 354 名抗 HCV 和/或抗 HIV 血清阳性居民。除了包括临床状态、ALT、AST、抗 HCV Abs 在内的与 HCV 相关的肝病变量,以及改变的 CD4+/CD8+T 细胞计数外,还检测了 HCV 核心抗原和 HCV 病毒载量。在合并 HIV-1 感染或不合并 HIV-1 感染的 CHC 患者中,血清 HCV 核心抗原浓度与 HCV RNA 水平高度相关。值得注意的是,HCV 核心抗原浓度与 CD4+T 细胞计数呈负相关,而 HCV RNA 水平与 CD4+T 细胞计数之间没有相关性。我们的研究结果表明,在评估 HCV/HIV-1 合并感染患者的 HCV 复制与宿主免疫状态之间的关系时,定量检测血浆 HCV 核心抗原可能是 HCV RNA qPCR 检测的替代指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed50/3155566/823e00df485d/pone.0023550.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed50/3155566/3bd8d7b24a11/pone.0023550.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed50/3155566/7b37c0138154/pone.0023550.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed50/3155566/d2675b05245c/pone.0023550.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed50/3155566/104a88b43f9b/pone.0023550.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed50/3155566/823e00df485d/pone.0023550.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed50/3155566/3bd8d7b24a11/pone.0023550.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed50/3155566/7b37c0138154/pone.0023550.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed50/3155566/d2675b05245c/pone.0023550.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed50/3155566/104a88b43f9b/pone.0023550.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed50/3155566/823e00df485d/pone.0023550.g005.jpg

相似文献

1
A higher correlation of HCV core antigen with CD4+ T cell counts compared with HCV RNA in HCV/HIV-1 coinfected patients.与 HCV RNA 相比,HCV 核心抗原与 HCV/HIV-1 共感染患者的 CD4+ T 细胞计数相关性更高。
PLoS One. 2011;6(8):e23550. doi: 10.1371/journal.pone.0023550. Epub 2011 Aug 12.
2
Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients.丙型肝炎病毒核心抗原和RNA定量检测在丙型肝炎病毒感染及丙型肝炎病毒/人类免疫缺陷病毒1型合并感染患者中的有效性
BMC Infect Dis. 2014 Nov 5;14:577. doi: 10.1186/s12879-014-0577-1.
3
HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals.在接受高效抗逆转录病毒治疗的 HIV/丙型肝炎病毒合并感染患者中,丙型肝炎病毒特异性 T 细胞应答与丙型肝炎病毒单感染个体中观察到的应答相当。
J Acquir Immune Defic Syndr. 2011 May 1;57(1):1-8. doi: 10.1097/qai.0b013e31821024e7.
4
Effect of coexisting HIV-1 infection on the diagnosis and evaluation of hepatitis C virus.合并感染人类免疫缺陷病毒1型对丙型肝炎病毒诊断和评估的影响。
J Acquir Immune Defic Syndr. 2001 Apr 1;26(4):340-4. doi: 10.1097/00126334-200104010-00008.
5
[A preliminary assessment of the clinical utility of measuring hepatitis C virus antibody to evaluate infection status].[检测丙型肝炎病毒抗体以评估感染状况的临床效用的初步评估]
Zhonghua Gan Zang Bing Za Zhi. 2014 Apr;22(4):244-50. doi: 10.3760/cma.j.issn.1007-3418.2014.04.002.
6
Transient liver injury associated with the early recovery of HCV-specific T-cell responses and HCV rebound in HIV-1/HCV coinfected patients undergoing highly active antiretroviral therapy.与 HIV-1/HCV 合并感染患者接受高效抗逆转录病毒治疗后 HCV 特异性 T 细胞反应早期恢复和 HCV 反弹相关的短暂性肝损伤。
J Acquir Immune Defic Syndr. 2013 Feb 1;62(2):135-42. doi: 10.1097/QAI.0b013e3182752d20.
7
Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.在接受抗逆转录病毒治疗的 HIV/HCV 合并感染患者中,表型激活的 CD38(+) HLA-DR(+) CD8(+) T 细胞而非 CD38(+) HLA-DR(+) CD4(+) T 细胞明显富集。
J Med Virol. 2016 Aug;88(8):1347-56. doi: 10.1002/jmv.24475. Epub 2016 Jan 20.
8
Higher dN/dS ratios in the HCV core gene, but not in the E1/HVR1 gene, are associated with human immunodeficiency virus-associated immunosuppression.HCV 核心基因中的 dN/dS 比值较高,但 E1/HVR1 基因中则没有,与人类免疫缺陷病毒相关的免疫抑制有关。
Arch Virol. 2012 Nov;157(11):2153-62. doi: 10.1007/s00705-012-1390-z. Epub 2012 Jul 24.
9
Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.中国大理地区HIV-1感染注射吸毒者中的乙型肝炎病毒和丙型肝炎病毒感染:一项横断面研究中的患病率及感染状况
Arch Virol. 2015 Apr;160(4):929-36. doi: 10.1007/s00705-014-2311-0. Epub 2015 Jan 24.
10
Hepatitis C plasma viral load is associated with HCV genotype but not with HIV coinfection.丙型肝炎血浆病毒载量与丙肝病毒基因型有关,但与合并感染艾滋病毒无关。
J Med Virol. 1996 Apr;48(4):339-43. doi: 10.1002/(SICI)1096-9071(199604)48:4<339::AID-JMV7>3.0.CO;2-8.

引用本文的文献

1
Polymorphisms in the Th17 cell-related RORC gene are associated with spontaneous clearance of HCV in Chinese women.Th17 细胞相关 RORC 基因的多态性与中国女性 HCV 的自发清除有关。
BMC Infect Dis. 2018 Jun 4;18(1):254. doi: 10.1186/s12879-018-3153-2.
2
Liver Damage in Patients with HCV/HIV Coinfection Is Linked to HIV-Related Oxidative Stress.丙型肝炎病毒/人类免疫缺陷病毒合并感染患者的肝损伤与艾滋病相关的氧化应激有关。
Oxid Med Cell Longev. 2016;2016:8142431. doi: 10.1155/2016/8142431. Epub 2016 Jan 10.
3
Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients.

本文引用的文献

1
Prevalence and risk factors for abnormal liver stiffness in HIV-infected patients without viral hepatitis coinfection: role of didanosine.无病毒性肝炎合并感染的HIV感染患者肝脏硬度异常的患病率及危险因素:去羟肌苷的作用
Antivir Ther. 2010;15(5):753-63. doi: 10.3851/IMP1612.
2
Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection.未合并乙型肝炎或丙型肝炎病毒感染的 HIV 感染者中丙氨酸氨基转移酶水平慢性升高的发生率和危险因素。
Clin Infect Dis. 2010 Feb 15;50(4):502-11. doi: 10.1086/649922.
3
Increased rate of death related to presence of viremia among hepatitis C virus antibody-positive subjects in a community-based cohort study.
丙型肝炎病毒核心抗原和RNA定量检测在丙型肝炎病毒感染及丙型肝炎病毒/人类免疫缺陷病毒1型合并感染患者中的有效性
BMC Infect Dis. 2014 Nov 5;14:577. doi: 10.1186/s12879-014-0577-1.
4
HIV co-infection accelerates decay of humoral responses in spontaneous resolvers of HCV infection.HIV 合并感染加速了 HCV 感染自发清除者中体液免疫反应的衰退。
J Viral Hepat. 2014 Oct;21(10):690-5. doi: 10.1111/jvh.12238. Epub 2014 Feb 12.
5
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes.不同丙型肝炎病毒(HCV)基因型的人类免疫缺陷病毒(HIV)/HCV 合并感染患者中的 HCV 核心抗原和 HCV-RNA
BMC Infect Dis. 2014 Apr 23;14:222. doi: 10.1186/1471-2334-14-222.
在一项基于社区的队列研究中,丙型肝炎病毒抗体阳性受试者中与病毒血症相关的死亡率增加。
Hepatology. 2009 Aug;50(2):393-9. doi: 10.1002/hep.23002.
4
Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy.接受抗逆转录病毒治疗的人类免疫缺陷病毒1型单感染患者不明原因转氨酶升高背后的肝损伤。
Hepatology. 2009 Feb;49(2):436-42. doi: 10.1002/hep.22665.
5
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies.高收入国家接受联合抗逆转录病毒治疗的个体的预期寿命:14项队列研究的协作分析
Lancet. 2008 Jul 26;372(9635):293-9. doi: 10.1016/S0140-6736(08)61113-7.
6
The prevalence and risk factors for abnormal liver enzymes in HIV-positive patients without hepatitis B or C coinfections.无乙肝或丙肝合并感染的HIV阳性患者肝酶异常的患病率及危险因素
Dig Dis Sci. 2008 May;53(5):1375-82. doi: 10.1007/s10620-007-9999-6. Epub 2007 Oct 16.
7
Severe liver disease associated with prolonged exposure to antiretroviral drugs.与长期暴露于抗逆转录病毒药物相关的严重肝病。
J Acquir Immune Defic Syndr. 2006 Jun;42(2):177-82. doi: 10.1097/01.qai.0000221683.44940.62.
8
Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.丙型肝炎病毒(HCV)血清学阳性献血者中HCV RNA阴性的相关因素
Transfusion. 2006 Mar;46(3):469-75. doi: 10.1111/j.1537-2995.2006.00745.x.
9
The effect of baseline CD4 cell count and HIV-1 viral load on the efficacy and safety of nevirapine or efavirenz-based first-line HAART.基线CD4细胞计数和HIV-1病毒载量对以奈韦拉平或依非韦伦为基础的一线高效抗逆转录病毒治疗的疗效和安全性的影响。
AIDS. 2005 Mar 25;19(5):463-71. doi: 10.1097/01.aids.0000162334.12815.5b.
10
Benefit of hepatitis C virus core antigen assay in prediction of therapeutic response to interferon and ribavirin combination therapy.丙型肝炎病毒核心抗原检测在预测干扰素与利巴韦林联合治疗疗效中的作用
J Clin Microbiol. 2005 Jan;43(1):186-91. doi: 10.1128/JCM.43.1.186-191.2005.